More Sleep: Pain Response to Longer Sleep

June 19, 2024 updated by: Anne-Marie Chang, Penn State University

Can More Sleep Improve Pain Responses, Symptomatology, and Regulation in College Students?

This study is being done to find out whether extending sleep for at least an hour per night, seven days a week, predicts a higher tolerance and a higher threshold for pain. This is a 21-day study. Participants will be asked to wear sleep- and heart- monitoring watches. Pressure pain and cold pain will be measured at study visits.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anne-Marie Chang, PhD
  • Phone Number: +18148635226
  • Email: auc35@psu.edu

Study Contact Backup

  • Name: Margeaux Gray, PhD
  • Phone Number: +18148635800
  • Email: mmg58@psu.edu

Study Locations

    • Pennsylvania
      • University Park, Pennsylvania, United States, 16802
        • Recruiting
        • Pennsylvania State University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 18 to 24 (inclusive) years of age at enrollment
  2. Fluent English speaker and reader
  3. Willing to refrain from initiating new therapeutic interventions (e.g., medication; behavioral) designed to target sleep or pain for the duration of study participation

Exclusion Criteria:

  1. Diagnosed with a sleep disorder
  2. Diagnosed with a pain disorder
  3. Has experienced a cold-related injury frostbite or has any other nerve damage to the feet
  4. Has a history of injury to any of the muscular measurement sites for pain (I.e. shoulder, jaw, forearm)
  5. Diagnosed with hypertension or cardiovascular disease
  6. Evidence of hypertension
  7. Diagnosed serious mental health disorder or substance use disorder
  8. Taking any physician-directed pharmacologic intervention for sleep
  9. Taking any physician-directed pharmacologic intervention for pain
  10. Personal health history of traumatic brain injury
  11. Pregnant
  12. Current smoker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep Extension
1 week of >1 hour increased time in bed
>1 hour additional time in bed per night for 1 week.
No Intervention: Control
Sustained sleep behavior

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pressure pain threshold from before to after sleep extension
Time Frame: Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Bilateral response to a clinically standard algometer at 3 different physical palpation sites. A higher pressure reading indicates a better pain response.
Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Change in pressure pain tolerance from before to after sleep extension
Time Frame: Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Bilateral response to a clinically standard algometer at 3 different physical palpation sites. A higher pressure reading indicates a better pain response.
Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Change in weekly average of momentary pain self-reports from before to after sleep extension
Time Frame: (averaged) Daily surveys during study week 1 (pre-intervention) and study week 2 (intervention)
Intermittent pain intensity using a Visual Analog Scale (0-100, where 0 = "no pain", 100 = "worst pain imaginable in current circumstances"). Higher values indicated more pain, and a negative change indicates a decrease in pain.
(averaged) Daily surveys during study week 1 (pre-intervention) and study week 2 (intervention)
Change in thermal pain threshold from before to after sleep extension
Time Frame: Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Latency to respond to a bilateral cold pressor test (feet). A longer latency to threshold indicates better pain response.
Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Change in thermal pain tolerance from before to after sleep extension
Time Frame: Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Latency to respond to a bilateral cold pressor test (feet). A longer latency to tolerance indicates better pain response.
Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Change in pain inhibition from before to after sleep extension
Time Frame: Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).
Pain inhibition is measured as the difference in pressure pain threshold from before to after cold pressor procedure. A reduction in pressure pain threshold is typical after cold pressor procedure. A greater reduction in pain threshold indicates a better response of the pain inhibitory system.
Momentary at study visit 2 (at the end of week1) and a week later at study visit 3 (at the end of week2).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 18, 2024

Primary Completion (Estimated)

April 30, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

March 20, 2023

First Submitted That Met QC Criteria

April 14, 2023

First Posted (Actual)

April 18, 2023

Study Record Updates

Last Update Posted (Actual)

June 21, 2024

Last Update Submitted That Met QC Criteria

June 19, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00022196

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

The data will be shared within one year after the first publication related to primary outcomes.

IPD Sharing Access Criteria

Request for data should be made in writing to the PI.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Sleep extension

3
Subscribe